Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02763449
Other study ID # AAA-1
Secondary ID
Status Not yet recruiting
Phase N/A
First received April 4, 2016
Last updated May 3, 2016
Start date May 2016
Est. completion date December 2018

Study information

Verified date May 2016
Source Iowa State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to understand what happens when someone either becomes more active or more inactive. This study will measure your energy intake, energy expenditure, and body composition under normal conditions, when you become active, and when you become inactive.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date December 2018
Est. primary completion date October 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 25 Years to 35 Years
Eligibility Inclusion Criteria:

- Men and women

- Age 25-35 yrs

- BMI =25.0 to <35.0 kg/m2

- Subjective physical activity (pre run-in): Sedentary for the previous 3 months (< 20min, 3 times/week of structured exercise)

- Objective physical activity (run-in): daily steps/day >4500 yet <7,000 during 7 day run-in period

- Weight-stable (± 5%) within the previous 3 months

- Non-smoking for last year

- Able to provide own transportation to study visits and intervention

- Not currently involved in any other research study

- Willing and able to participate in all aspects of the trial including research testing

- Willing to give informed consent to participate

- Able to participate in a moderate physical exercise program

Exclusion Criteria:

- Self-reported significant cardiovascular disease including but not limited to serious arrhythmias, cardiomyopathy, congestive heart failure, myocardial infarction, stroke

- Other self-reported medical conditions including but not limited to metabolic disorders such as diabetes, chronic or recurrent respiratory conditions, active cancer, musculoskeletal disease interfering with exercise, or any serious medical condition that may affect adherence to the protocol or exercising safely, or be aggravated by exercise

- Medications known to affect exercise performance or metabolism (e.g. thyroid medication, beta-blockers, or stimulants)

- Excess caffeine use (> 500mg/day)

- Restrained eater (>13) on the restraint section of the three-factor eating questionnaire

- Current or past diagnosis of an eating disorder

- Any self-reported contraindications to exercise according to the American College of Sports Medicine criteria

- Pregnant or actively trying to become pregnant

- Gave birth in the past 12 months or <6 months post-lactation

- Other medical, psychiatric or behavioral factors that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol.

- Known allergy to the metal nickel

- Known allergies to pasta or tomato sauce

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Physical Activity and Sedentary Behavior

Intervention

Behavioral:
Self-monitoing
Participants will self-monitor their physical activity level via activity monitors

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Iowa State University

Outcome

Type Measure Description Time frame Safety issue
Primary Appetite- subjective Change in appetite will be assessed through subjective ratings of hunger and fullness 14 days No
Secondary Appetite- objective Change in appetite will be assessed through objective measures of appetite-related hormones 14 days No
See also
  Status Clinical Trial Phase
Completed NCT03439852 - Modifying Physical Activity and Sedentary Time in Filipino Faith Leaders N/A